Search Results
Mar 12, 2026, 08:00 ET MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026
approach significantly increases diagnostic yield and clinical utility over legacy exome methods, providing the necessary foundation for MyOme's multi-omic innovations.[3]
More news about: MyOme, Inc
Mar 12, 2026, 07:00 ET PreludeDx Announces Publication in Breast Cancer Research Validating AidaBreast™, the Only Multi-Omic Test to Predict Locoregional Recurrence Risk and Radiation Therapy Benefit in Early-Stage Invasive Breast Cancer
enable clinicians to escalate and de-escalate therapy based on molecular biology."This publication validates the strength of our multi-omic platform," said Troy Bremer, PhD, Chief Scientific Officer of PreludeDx. "By integrating the multiplex platform and spatial biology, AidaBreast captures
More news about: Prelude Corporation
Feb 26, 2026, 19:24 ET Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics
boundaries of oncology, powered by Illumina's spatial transcriptomics, 5-base sequencing, and proteomics technologies. The ability to combine more than one omic insight reveals unprecedented biological depth and knowledge, all of which is streamlined by Illumina Connected Multiomics for multimodal data analysis.
More news about: Illumina
Feb 25, 2026, 09:15 ET Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
breakthroughs in oncology powered by Illumina's spatial transcriptomics, 5-base sequencing, and proteomics technologies. The ability to combine more than one omic insight reveals unprecedented biological depth and knowledge, all of which is streamlined by Illumina Connected Multiomics for multimodal data analysis.
More news about: Illumina, Inc.
Feb 23, 2026, 12:00 ET New Gentle Methyl Conversion Kit Delivers High-Accuracy Profiling from as Little as 100 pg of DNA
PELOBiotech (EU), Stratech Scientific (UK), Eagle Biosciences (US), and AS ONE (Japan). About Ellis Bio Ellis Bio, Inc. is developing multi-omic tools and technologies that enable researchers, clinicians, and drug developers to capture the full complexity of the DNA and RNA landscape. Spun out
More news about: Ellis Bio Inc
Jan 22, 2026, 08:00 ET The Brain Aneurysm Foundation Highlights Recent Advances from its Research Grantees
characterize inflammatory cell populations within human intracranial aneurysms and was published in Neurology. This work informs ongoing multi-omic and translational efforts to develop immune-based biomarkers and targeted therapies to modify aneurysm progression and rupture risk.Antonios
More news about: Brain Aneurysm Foundation
Jan 21, 2026, 08:00 ET Variant Bio Appoints Craig T. Basson, MD, PhD, to Advance Genomics-Driven Clinical Programs
multiple therapeutic areas. The company's research is powered by its proprietary Inference platform, which integrates across deep phenotyping and multi-omic data using statistical genetics and AI/ML approaches to identify and validate therapeutic targets. With ethics at its core, the company launched an
More news about: Variant Bio
Jan 08, 2026, 08:00 ET Factorial Biotechnologies and Honeycomb Biotechnologies Partner to Deliver High-Throughput, Instrument-Free Single-Cell DNA Sequencing
Factorial's in-cell library preparation technology, researchers can now extend these capabilities to comprehensive single-cell DNA analysis and multi-omic profiling."Extending the HIVE platform to instrument-free single-cell DNA sequencing will accelerate discoveries in somatic mosaicism, tumor
More news about: Factorial Biotechnologies
Jan 06, 2026, 07:03 ET Variant Bio Launches Inference, the World's First Agentic AI Genomic Drug Discovery Platform
Platform integrates proprietary and public genetic and multi-omic data with cutting-edge AI to transform drug discoveryInference Agents autonomously execute PhD-level analyses using Model Context Protocol (MCP)Platform now available to pharmaceutical research partners;
More news about: Variant Bio
Jan 06, 2026, 07:00 ET Variant Bio Announces Strategic Target Discovery Collaboration with Boehringer Ingelheim for Kidney Disease
cardiorenal and kidney disease, leveraging Variant Bio's AI-powered Inference platform, which integrates proprietary genomic, deep phenotyping, and multi-omic data from studies with global populations.
More news about: Variant Bio
Dec 27, 2025, 05:00 ET Best Pace of Aging Test (2026): TruDiagnostic Recognized for DunedinPace Innovation by Expert Consumers
view of biological age and organ-system health.The kit delivers:A Biological Age Score (OMICmAge) using multi-omic methylation and biomarker analysis, developed in collaboration with a leading academic institution.11 organ-system age scores (covering
More news about: ExpertConsumers.org
Dec 19, 2025, 13:07 ET Wasatch BioLabs Announces Co-Marketing Agreement With Agilent to Advance Native-Read Targeted Sequencing
genomic DNA and Avida for cell-free DNA—and WBL's proprietary Oxford Nanopore-based native-read workflow, expanding access to scalable targeted multi-omic analysis for RUO and clinical research studies.
More news about: Wasatch BioLabs
Dec 10, 2025, 07:00 ET PreludeDx Announces First Independent Validation of AidaBreast™, the Only Multi-Omic Test to Predict Locoregional Recurrence Risk and Radiation Therapy Benefit in Early-Stage Invasive Breast Cancer
in precision diagnostics for early-stage breast cancer, today announced results from the first independent validation of AidaBreast™, a novel multi-omic biosignature developed to predict a woman's 10-year risk of locoregional recurrence (LRR) and her individualized benefit from adjuvant radiation therapy
More news about: Prelude Corporation
Dec 04, 2025, 08:30 ET Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium
NCI-designated cancer centers."SABCS is the premier global stage for advancing breast cancer research, and we are excited to share how Caris' multi-omic tumor profiling is helping define molecularly distinct patient groups," said
More news about: Caris Life Sciences
Dec 02, 2025, 08:00 ET Insilico Medicine and Atossa Therapeutics Publish AI-Driven Study in Nature Scientific Reports Identifying (Z)-Endoxifen as a Potential Therapeutic Candidate for Glioblastoma
and showing enhanced effects in combination. In vivo studies confirmed that endoxifen was well tolerated across all doses. Together, the multi-omic analyses and experimental findings highlight endoxifen as a promising therapeutic candidate for GBM and showcase how AI-powered discovery can reveal
More news about: Atossa Therapeutics Inc
Nov 20, 2025, 08:00 ET ALS Network and ALS United Announce New Research Grantees
Therapy. Richard Daneman, PhD; John Ravits, MD, University of California San Diego for Multi-omic Analysis of Cerebrovascular Changes in Patients with ALS. Faranak Fattahi, PhD; Sarah
More news about: ALS Network
Nov 18, 2025, 05:40 ET Oncology Molecular Diagnostics Market to Reach US$ 6.46 Billion by 2033, Driven by Precision Oncology, and Accelerating Biomarker-Based Therapies - According to DataM Intelligence
indispensable, with AI-driven genomic analysis, variant interpretation tools, and clinical decision-support platforms streamlining the complexities of multi-omic data. Buy This Report with Year-End Offer (Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50% OFF
More news about: DataM Intelligence 4 Market Research LLP
Nov 10, 2025, 12:15 ET Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks
market at the lowest cost per protein target for more than 40 customers across 16 sites globally. Labs of all sizes are creating powerful layers of omic data for a range of diseases that enrich datasets generated by biobank programs around the world.
More news about: Illumina, Inc.
Nov 07, 2025, 08:58 ET Resonant Wins BioTech Breakthrough Awards' "DNA Sequencing Innovation Of The Year"
types are responding in real-time, fast enough to matter. The platform delivers cleaner interpretation, greater specificity, and potential for multi-omic biomarker integration. Resonant's cell-type-resolved readout links biomarker change to disease mechanism: cortical neurons in Alzheimer's, dopaminergic
More news about: Resonant
Nov 03, 2025, 10:35 ET Answer ALS Completes Release of Full Dataset and Integrates ALS TDI ARC Study Data into Neuromine
layers of "omics" data for each patient, all rigorously processed to ensure the highest quality. "We've been building and refining the Answer ALS multi-omic dataset for years, now with over 1,100 deeply characterized participants," said Terri Thompson, Ph.D., Program Director of Data Management at Answer
More news about: Answer ALS
Oct 16, 2025, 09:15 ET Genomics launches Mystra: the world's first and original AI-enabled human genetics platform, now available to transform drug target discovery and clinical development
faster." The platform will be the first ever fully scalable solution available to life sciences companies for the use of multi-omic data for R&D. Omics data is heterogeneous and requires specialist expertise and complex methods to harmonize, analyze, and extract meaningful and
More news about: Genomics
Oct 15, 2025, 23:53 ET Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
disease cases Proprietary 5-base chemistry and novel DRAGEN algorithms enable dual-omic inquiry, providing researchers with new tool for precision medicine breakthroughs
More news about: Illumina
Oct 15, 2025, 09:15 ET Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
disease cases Proprietary 5-base chemistry and novel DRAGEN algorithms enable dual-omic inquiry, providing researchers with new tool for precision medicine breakthroughs
More news about: Illumina, Inc.
Oct 13, 2025, 08:43 ET AccuGenomics and 1Cell.Ai Partner to Bring Ultra-Sensitive Liquid Biopsy Testing Across Asia, with Plans for U.S. Expansion
Collaboration integrates per-sample NGS internal standards with multi-omic precision oncology platform to enhance cancer diagnostics accuracy and access WILMINGTON, N.C.
More news about: AccuGenomics
Oct 08, 2025, 09:31 ET India's No: 1 Ranked Institute, IIT Madras & Danish University Study reveals Genetic 'Switches' that can transform Disease Research
10.1038/s41467-025-63306-4), an open-access journal also published by Springer Nature. In this study, the researchers, using systems-level multi-omic approaches, showed how genetic variants in yeast work together to activate previously dormant metabolic pathways. By revealing how these gene–gene interactions
More news about: IIT Madras